Latest & greatest articles for knee replacement

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on knee replacement or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on knee replacement and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for knee replacement

141. Do we need a gender-specific total knee replacement? A randomised controlled trial comparing a high-flex and a gender-specific posterior design (Abstract)

Do we need a gender-specific total knee replacement? A randomised controlled trial comparing a high-flex and a gender-specific posterior design The purpose of this study was to investigate whether a gender-specific high-flexion posterior-stabilised (PS) total knee replacement (TKR) would offer advantages over a high-flex PS TKR regarding range of movement (ROM), 'feel' of the knee, pain and satisfaction, as well as during activity. A total of 24 female patients with bilateral osteoarthritis (...) entered this prospective, blind randomised trial in which they received a high-flex PS TKR in one knee and a gender-specific high-flexion PS TKR in the other knee. At follow-up, patients were assessed clinically measuring ROM, and questioned about pain, satisfaction and daily 'feel' of each knee. Patients underwent gait analysis pre-operatively and at one year, which yielded kinematic, kinetic and temporospatial parameters indicative of knee function during gait. At final follow-up we found

2012 EvidenceUpdates Controlled trial quality: uncertain

142. Dabigatran, rivaroxaban, or apixaban versus enoxaparin for thromboprophylaxis after total hip or knee replacement: systematic review, meta-analysis, and indirect treatment comparisons Full Text available with Trip Pro

Dabigatran, rivaroxaban, or apixaban versus enoxaparin for thromboprophylaxis after total hip or knee replacement: systematic review, meta-analysis, and indirect treatment comparisons Dabigatran, rivaroxaban, or apixaban versus enoxaparin for thromboprophylaxis after total hip or knee replacement: systematic review, meta-analysis, and indirect treatment comparisons Dabigatran, rivaroxaban, or apixaban versus enoxaparin for thromboprophylaxis after total hip or knee replacement: systematic (...) review, meta-analysis, and indirect treatment comparisons Gomez-Outes A, Terleira-Fernandez AI, Suarez-Gea L, Vargas-Castrillon E CRD summary This generally well-conducted review concluded that higher efficacy in prevention of symptomatic venous thromboembolism in new anticoagulants following total knee or hip replacement was associated with a higher risk of bleeding. This conclusion accurately reflects the evidence and is likely to be reliable. Authors' objectives To assess clinical outcomes

2012 DARE.

143. Long-Term Comparison of Fixed-Bearing and Mobile-Bearing Total Knee Replacements in Patients Younger Than Fifty-one Years of Age with Osteoarthritis (Abstract)

Long-Term Comparison of Fixed-Bearing and Mobile-Bearing Total Knee Replacements in Patients Younger Than Fifty-one Years of Age with Osteoarthritis There is limited information comparing the results of fixed-bearing total knee replacement and mobile-bearing total knee replacement in patients with osteoarthritis who are younger than fifty-one years and who have a fixed-bearing implant in one knee and a mobile-bearing implant in the other. The purpose of this study was to compare our long-term (...) clinical and radiographic results of fixed-bearing total knee replacement and mobile-bearing total knee replacement in a group of patients from this population.We prospectively compared the results of 108 patients with osteoarthritis who were younger than fifty-one years (mean age, forty-five years) who had received a fixed-bearing prosthesis in one knee and a rotating platform mobile-bearing prosthesis in the other. The mean follow-up was 16.8 years (range, fifteen to eighteen years). The patients

2012 EvidenceUpdates

144. Oral direct factor Xa inhibitors versus low-molecular-weight heparin to prevent venous thromboembolism in patients undergoing total hip or knee replacement: a systematic review and meta-analysis

Oral direct factor Xa inhibitors versus low-molecular-weight heparin to prevent venous thromboembolism in patients undergoing total hip or knee replacement: a systematic review and meta-analysis Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2012 DARE.

145. Oral Direct Factor Xa Inhibitors Versus Low-Molecular-Weight Heparin to Prevent Venous Thromboembolism in Patients Undergoing Total Hip or Knee Replacement: A Systematic Review and Meta-analysis. (Abstract)

Oral Direct Factor Xa Inhibitors Versus Low-Molecular-Weight Heparin to Prevent Venous Thromboembolism in Patients Undergoing Total Hip or Knee Replacement: A Systematic Review and Meta-analysis. Thromboembolic disease is the most frequent medical complication of arthroplasty.To evaluate the benefits and harms of oral direct factor Xa inhibitors versus low-molecular-weight heparin (LMWH) in patients undergoing total hip or knee replacement.MEDLINE (1966 to December 2011), EMBASE (1980 (...) to December 2011), and the Cochrane Central Register of Controlled Trials (up to December 2011), without language restrictions. References of reviews and abstracts of conferences were hand-searched.Randomized trials in patients undergoing hip or knee replacement that evaluated factor Xa inhibitors versus LMWH.Two reviewers independently evaluated eligibility, abstracted the data, and assessed risk for bias.In 22 trials, high-quality evidence indicated that the absolute effect of factor Xa inhibitors

2012 Annals of Internal Medicine

146. Knee replacement. (Abstract)

Knee replacement. Knee-replacement surgery is frequently done and highly successful. It relieves pain and improves knee function in people with advanced arthritis of the joint. The most common indication for the procedure is osteoarthritis. We review the epidemiology of and risk factors for knee replacement. Because replacement is increasingly considered for patients younger than 55 years, improved decision making about whether a patient should undergo the procedure is needed. We discuss (...) assessment of surgery outcomes based on data for revision surgery from national joint-replacement registries and on patient-reported outcome measures. Widespread surveillance of existing implants is urgently needed alongside the carefully monitored introduction of new implant designs. Developments for the future are improved delivery of care and training for surgeons and clinical teams. In an increasingly ageing society, the demand for knee-replacement surgery will probably rise further, and we predict

2012 Lancet

147. Tranexamic acid in total knee replacement: A systematic review and meta-analysis Full Text available with Trip Pro

Tranexamic acid in total knee replacement: A systematic review and meta-analysis We conducted a systematic review and meta-analysis of randomised controlled trials evaluating the effect of tranexamic acid (TXA) upon blood loss and transfusion in primary total knee replacement. The review used the generic evaluation tool designed by the Cochrane Bone, Joint and Muscle Trauma Group. A total of 19 trials were eligible: 18 used intravenous administration, one also evaluated oral dosing and one

2012 EvidenceUpdates

148. The effect of early mobilisation of patients who have undergone a hip or knee joint replacement on length of stay in hospital: a systematic review

The effect of early mobilisation of patients who have undergone a hip or knee joint replacement on length of stay in hospital: a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith

2012 PROSPERO

149. The impact of implant malalignment in total knee replacement on patient outcome: a systematic review of the literature

The impact of implant malalignment in total knee replacement on patient outcome: a systematic review of the literature Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence

2012 PROSPERO

150. A systematic review of the association of patient factors with outcome after total knee replacement

A systematic review of the association of patient factors with outcome after total knee replacement Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web

2012 PROSPERO

151. Apixaban for the prevention of venous thromboembolism after total hip or knee replacement in adults (TA245)

Apixaban for the prevention of venous thromboembolism after total hip or knee replacement in adults (TA245) Overview | Apixaban for the prevention of venous thromboembolism after total hip or knee replacement in adults | Guidance | NICE Apixaban for the prevention of venous thromboembolism after total hip or knee replacement in adults Technology appraisal guidance [TA245] Published date: 25 January 2012 Share Guidance on apixaban (Eliquis) for preventing venous thromboembolism after total hip (...) or knee replacement in adults. Guidance development process Is this guidance up to date? . We found nothing new that affects the recommendations in this guidance. Next review : This guidance will be reviewed if there is new evidence that is likely to change the recommendations. Your responsibility The recommendations in this guidance represent the view of NICE, arrived at after careful consideration of the evidence available. When exercising their judgement, health professionals are expected to take

2012 National Institute for Health and Clinical Excellence - Technology Appraisals

152. Partial replacement of the meniscus of the knee using a biodegradable scaffold (IPG430)

Partial replacement of the meniscus of the knee using a biodegradable scaffold (IPG430) Overview | Partial replacement of the meniscus of the knee using a biodegradable scaffold | Guidance | NICE Partial replacement of the meniscus of the knee using a biodegradable scaffold Interventional procedures guidance [IPG430] Published date: July 2012 Share Save Guidance The National Institute for Health and Clinical Excellence (NICE) has issued full guidance to the NHS in England, Wales, Scotland (...) and Northern Ireland on partial replacement of the meniscus of the knee using a biodegradable scaffold. Description The meniscus is a crescent-shaped cartilage inside either side of the knee. It acts as a shock absorber between the long bones of the leg. It can be damaged by injury or overuse, causing pain, swelling and locking of the knee. In this procedure, a biodegradable implant is placed into the meniscus by ‘keyhole’ knee surgery. The implant works as a scaffold to support re-growth and repair

2012 National Institute for Health and Clinical Excellence - Interventional Procedures

153. Cohart Study: The efficacy of psychosocial factors in predicting pain and functional outcomes following knee replacement surgery Full Text available with Trip Pro

Cohart Study: The efficacy of psychosocial factors in predicting pain and functional outcomes following knee replacement surgery The efficacy of psychosocial factors in predicting pain and functional outcomes following knee replacement surgery | Evidence-Based Nursing We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your (...) username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here The efficacy of psychosocial factors in predicting pain and functional outcomes following knee replacement surgery Article Text Care of the older person

2012 Evidence-Based Nursing

154. Patellar resurfacing in primary total knee replacement: a meta-analysis (Abstract)

Patellar resurfacing in primary total knee replacement: a meta-analysis Treatment of the patella during total knee replacement is an area of continuing debate. We performed a meta-analysis of randomized controlled trials to address the hypothesis that patellar resurfacing in primary total knee replacement improved patient outcome.Randomized controlled trials comparing patellar resurfacing with nonresurfacing in primary total knee replacement were included. The primary outcomes analyzed were (...) knee scores, anterior knee pain, and patient satisfaction. We also investigated the prevalence of complications, revision surgery related specifically to the patellofemoral joint, the infection rate, operative time, and radiographic appearance.Sixteen randomized controlled trials assessing 3465 knee replacements were eligible; 1710 procedures included patellar resurfacing and 1755 did not. The knee component of the Knee Society Score was significantly higher in the resurfacing group (p = 0.005

2012 EvidenceUpdates

155. Joint line position correlates with function after primary total knee replacement: a randomised controlled trial comparing conventional and computer-assisted surgery Full Text available with Trip Pro

Joint line position correlates with function after primary total knee replacement: a randomised controlled trial comparing conventional and computer-assisted surgery The role of computer-assisted surgery in maintaining the level of the joint in primary knee joint replacement (TKR) has not been well defined. We undertook a blinded randomised controlled trial comparing joint-line maintenance, functional outcomes, and quality-of-life outcomes between patients undergoing computer-assisted

2011 EvidenceUpdates Controlled trial quality: uncertain

156. A randomised, controlled trial of circumpatellar electrocautery in total knee replacement without patellar resurfacing Full Text available with Trip Pro

A randomised, controlled trial of circumpatellar electrocautery in total knee replacement without patellar resurfacing The efficacy of circumpatellar electrocautery in reducing the incidence of post-operative anterior knee pain is unknown. We conducted a single-centre, outcome-assessor and patient-blinded, parallel-group, randomised, controlled trial to compare circumpatellar electrocautery with no electrocautery in total knee replacement in the absence of patellar resurfacing. Patients (...) requiring knee replacement for primary osteoarthritis were randomly assigned circumpatellar electrocautery (intervention group) or no electrocautery (control group). The primary outcome measure was the incidence of anterior knee pain. A secondary measure was the standardised clinical and patient-reported outcomes determined by the American Knee Society scores and the Western Ontario and McMaster Universities (WOMAC) osteoarthritis index. A total of 131 knees received circumpatellar electrocautery

2011 EvidenceUpdates Controlled trial quality: predicted high

157. Inflammation related to synovectomy during total knee replacement in patients with primary osteoarthritis: a prospective, randomised study Full Text available with Trip Pro

Inflammation related to synovectomy during total knee replacement in patients with primary osteoarthritis: a prospective, randomised study We compared inflammation in the knee after total knee replacement (TKR) for primary osteoarthritis between two groups of patients undergoing joint replacement with and without synovectomy. A total of 67 patients who underwent unilateral TKR were randomly divided into group I, TKR without synovectomy, and group II, TKR with synovectomy. Clinical outcomes (...) , serial serum inflammatory markers (including interleukin-6 (IL-6), CRP and ESR) and the difference in temperature of the skin of the knee, compared with the contralateral side, were sequentially evaluated until 26 weeks after surgery. Pre-operatively, there were no statistically different clinical parameters between groups I and II. At the 26-week follow-up, both groups had a similarly significantly improved American Knee Society clinical score (p < 0.001) and functional score (p < 0.001

2011 EvidenceUpdates Controlled trial quality: uncertain

158. Thromboprophylactic treatment with rivaroxaban or dabigatran compared with enoxaparin or dalteparin in patients undergoing elective hip- or knee replacement surgery

Thromboprophylactic treatment with rivaroxaban or dabigatran compared with enoxaparin or dalteparin in patients undergoing elective hip- or knee replacement surgery Thromboprophylactic treatment with rivaroxaban or dabigatran compared with enoxaparin or dalteparin in patients undergoing elective hip- or knee replacement surgery Thromboprophylactic treatment with rivaroxaban or dabigatran compared with enoxaparin or dalteparin in patients undergoing elective hip- or knee replacement surgery (...) Ringerike T, Hamidi V, Hagen G, Reikvam A, Klemp M Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Ringerike T, Hamidi V, Hagen G, Reikvam A, Klemp M. Thromboprophylactic treatment with rivaroxaban or dabigatran compared with enoxaparin or dalteparin in patients undergoing elective hip- or knee replacement surgery. Oslo: Norwegian Knowledge Centre

2011 Health Technology Assessment (HTA) Database.

159. Cost-effectiveness of total hip and knee replacements for the Australian population with osteoarthritis: discrete-event simulation model Full Text available with Trip Pro

Cost-effectiveness of total hip and knee replacements for the Australian population with osteoarthritis: discrete-event simulation model Cost-effectiveness of total hip and knee replacements for the Australian population with osteoarthritis: discrete-event simulation model Cost-effectiveness of total hip and knee replacements for the Australian population with osteoarthritis: discrete-event simulation model Higashi H, Barendregt JJ Record Status This is a critical abstract of an economic (...) evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. CRD summary The objective was to evaluate the cost-effectiveness of total hip or knee replacements, in Australia, accounting for left and right joint replacements in each patient. The authors concluded that both hip and knee replacements were cost-effective

2011 NHS Economic Evaluation Database.

160. Equity in access to total joint replacement of the hip and knee in England: cross sectional study. Full Text available with Trip Pro

Equity in access to total joint replacement of the hip and knee in England: cross sectional study. To explore geographical and sociodemographic factors associated with variation in equity in access to total hip and knee replacement surgery.Combining small area estimates of need and provision to explore equity in access to care.English census wards.Patients throughout England who needed total hip or knee replacement and numbers who received surgery.Predicted rates of need (derived from (...) % confidence interval 0.65 to 0.72) and less total knee replacement (0.87, 0.82 to 0.93). Compared with women, men received more provision relative to need for total hip replacement (1.08, 1.05 to 1.10) and total knee replacement (1.31, 1.28 to 1.34). Compared with the least deprived, residents in the most deprived areas got less provision relative to need for total hip replacement (0.31, 0.30 to 0.33) and total knee replacement (0.33, 0.31 to 0.34). For total knee replacement, those in urban areas got

2010 BMJ